Hysterosalpingography (HSG) Market size is expected to grow at a CAGR of 6.30% throughout the forecast period, reaching nearly US$ 2.74 Bn. by 2029.Hysterosalpingography (HSG) Market Definition
Hysterosalpingography, or HSG, is an X-ray test to outline the internal shape of the uterus and show whether the fallopian tubes are blocked. It's also used to investigate miscarriages due to problems in the uterus.To know about the Research Methodology :- Request Free Sample Report
Hysterosalpingography (HSG) Market Dynamics
The global hysterosalpingography market is driven by technological advancement in hysterosalpingography procedures and increasing benefits in the concerns of patient care. The increasing prevalence of genetic disorders like Down syndrome, ONTD, and other genetic disorders are the driving factors for the global market. Rising consanguineous relations and physical relation in them increase the consciousness in the couples, which help to grow the global hysterosalpingography market. Growing laboratory applications of non-invasive hysterosalpingography are the opportunity for the global market to detect the disorders before childbirth. The emergence of new market entrants and local market players with low-cost products gives lucrative opportunities in the forecast period. The high availability of hysterosalpingography devices and the presence of a large number of manufacturers are expected to boost the demand for hysterosalpingography globally. The occurrence of infections and bleeding as well as complications faced during HSC testing may restrain the growth of the global market.Hysterosalpingography (HSG) Market Segment Analysis:
The report groups the Global Hysterosalpingography (HSG) Market in different segments Application, and Region to forecast the revenues and analyze the market share of each segment over the forecast period.Based on Application, the Global Hysterosalpingography (HSG) Market is segmented into Uterine Malformations, Asherman's syndrome, Tubal occlusion, Pelvic inflammatory disease. The Uterine malformations segment was dominant in 2021 and is expected to command a market share of xx% by 2029. Birth cases having the birth defect and the unknown causes of a congenital anomaly are detected recently by the hysterosalpingography laboratory techniques. The prevalence of uterine malformation is estimated to be 6.7% in the general population, slightly higher in the infertility population, and significantly higher in a population of women with a history of recurrent miscarriages. These increasing numbers of patients are driving the global market. The technological developments in the 3-dimensional ultrasound or magnetic resonance image-guided systems along with hysterosalpingography procedures are giving the wide opportunity for the global market.
Hysterosalpingography (HSG) Market Regional Analysis:
North America is expected to command the largest market share of xx% by 2029. Hysterosalpingography (HSG) has become a commonly performed examination in North America due to recent advances and improvements as well as the increasing popularity of reproductive medicine. Ongoing research on the HSC conducts for the detection of abnormalities related to the uterus and fallopian tubes. An increase in the number of pregnant women detected at HSG includes congenital anomalies, polyps, leiomyomas, surgical changes, synechiae, and adenomyosis. Professionals of North America estimated that HSG remains a valuable tool in the evaluation of the uterus and fallopian tubes. The radiologists from the region have the operation with HSG techniques operation and the knowledge about interpretation of HSG images are the growth factors for the global market in this region. The objective of the report is to present a comprehensive analysis of the Global Hysterosalpingography (HSG) Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Hysterosalpingography (HSG) Market dynamics, structure by analyzing the market segments and projects the Global Hysterosalpingography (HSG) Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Hysterosalpingography (HSG) Market make the report investor’s guide.Hysterosalpingography (HSG) Market Scope: Inquire before buying
Global Hysterosalpingography (HSG) Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US$ 2.02 Bn. Forecast Period 2022 to 2029 CAGR: 6.30% Market Size in 2029: US$ 2.74 Bn. Segments Covered: by Application • Uterine Malformations • Asherman’s syndrome • Tubal occlusion • Pelvic inflammatory disease Hysterosalpingography (HSG) Market, by Region:
• Asia Pacific • North America • Europe • Latin America • Middle East AfricaHysterosalpingography (HSG) Market Key Players
• Fairview Health Services • Atlantic OB-GYN • TRA-MINW • Shady Grove Fertility • Southwest Medical Center • Summit Medical Group • Reproductive Medicine Institute • Crozer-Keystone Health System • South Florida Institute for Reproductive Medicine and Lake Imaging • Halotech DNA • SCSA Diagnostics Inc. • Andrology Solutions • Zydus Cadila Healthcare Ltd • Androvia LifeSciences • Aetna Inc. • Bayer Healthcare • EMD Serono Inc Frequently Asked Questions: 1. Which region has the largest share in Global Hysterosalpingography (HSG) Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Hysterosalpingography (HSG) Market? Ans: The Global Hysterosalpingography (HSG) Market is growing at a CAGR of 6.30% during forecasting period 2022-2029. 3. What is scope of the Global Hysterosalpingography (HSG) market report? Ans: Global Hysterosalpingography (HSG) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Hysterosalpingography (HSG) market? Ans: The important key players in the Global Hysterosalpingography (HSG) Market are – Fairview Health Services, Atlantic OB-GYN, TRA-MINW, Shady Grove Fertility, Southwest Medical Center, Summit Medical Group, Reproductive Medicine Institute, Crozer-Keystone Health System, South Florida Institute for Reproductive Medicine and Lake Imaging, Halotech DNA, SCSA Diagnostics Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences, Aetna Inc., Bayer Healthcare, and EMD Serono Inc 5. What is the study period of this market? Ans: The Global Hysterosalpingography (HSG) Market is studied from 2021 to 2029.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Hysterosalpingography (HSG) Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Global Global Hysterosalpingography (HSG) Market 3.4. Geographical Snapshot of the Global Global Hysterosalpingography (HSG) Market, By Manufacturer share 4. Global Hysterosalpingography (HSG) Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Hysterosalpingography (HSG) Market 5. Supply Side and Demand Side Indicators 6. Global Hysterosalpingography (HSG) Market Analysis and Forecast, 2021-2029 6.1. Global Hysterosalpingography (HSG) Market Size & Y-o-Y Growth Analysis. 7. Global Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 7.1.1. Uterine Malformations 7.1.2. Asherman’s syndrome 7.1.3. Tubal occlusion 7.1.4. Pelvic inflammatory disease 8. Global Hysterosalpingography (HSG) Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 9.1.1. Uterine Malformations 9.1.2. Asherman’s syndrome 9.1.3. Tubal occlusion 9.1.4. Pelvic inflammatory disease 10. North America Hysterosalpingography (HSG) Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 12. Canada Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 13. Mexico Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 14. Europe Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 15. Europe Hysterosalpingography (HSG) Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 17. France Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 18. Germany Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 19. Italy Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 20. Spain Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 21. Sweden Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 22. CIS Countries Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 23. Rest of Europe Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 24. Asia Pacific Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 25. Asia Pacific Hysterosalpingography (HSG) Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 27. India Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 28. Japan Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 29. South Korea Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 30. Australia Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 31. ASEAN Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 32. Rest of Asia Pacific Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 33. Middle East Africa Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 34. Middle East Africa Hysterosalpingography (HSG) Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 36. GCC Countries Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 37. Egypt Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 38. Nigeria Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 39. Rest of ME&A Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 40. South America Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 41. South America Hysterosalpingography (HSG) Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 43. Argentina Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 44. Rest of South America Hysterosalpingography (HSG) Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Application, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Hysterosalpingography (HSG) Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1 Fairview Health Services 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Atlantic OB-GYN 45.3.3. TRA-MINW 45.3.4. Shady Grove Fertility 45.3.5. Southwest Medical Center 45.3.6. Summit Medical Group 45.3.7. Reproductive Medicine Institute 45.3.8. Crozer-Keystone Health System 45.3.9. South Florida Institute for Reproductive Medicine and Lake Imaging 45.3.10. Halotech DNA 45.3.11. SCSA Diagnostics Inc. 45.3.12. Andrology Solutions 45.3.13. Zydus Cadila Healthcare Ltd 45.3.14. Androvia LifeSciences 45.3.15. Aetna Inc. 45.3.16. Bayer Healthcare 45.3.17. EMD Serono Inc 46. Primary Key Insights